Physician profile
Arjun H Patel
NPI 1326276619
$4,144.39
in general payments reported to CMS, 2019-2025
40 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $107 · 2021: $112 · 2022: $161 · 2023: $575 · 2024: $1,751 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,421 · Travel and Lodging: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,420.75 |
| Travel and Lodging | $190.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,195.89 | 2023-2024 | |
| Microport Orthopedics INC | $447.44 | 2025 | Mpo Medial Pivot Knee |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $384.96 | 2022-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $372.43 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $365.80 | 2019-2025 | Andexxa, Farxiga, Airsupra |
| Novo Nordisk INC | $140.73 | 2024-2025 | Ozempic, Rybelsus |
| Integra Lifesciences Corporation | $114.06 | 2025 | Integra, Surgimend, Omnigraft |
| Paratek Pharmaceuticals, INC. | $100.21 | 2023-2024 | Nuzyra |
| Baxter Healthcare | $75.46 | 2023-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Madrigal Pharmaceuticals | $64.23 | 2025 | Rezdiffra |
| Vertex Pharmaceuticals Incorporated | $63.92 | 2025 | |
| Stryker Corporation | $61.13 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Scientific Affairs, LLC | $58.37 | 2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $55.67 | 2023-2025 | |
| Chiesi USA, INC. | $44.65 | 2022-2025 | Cleviprex |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.25 | 2019-2021 | |
| Neurelis, INC. | $35.93 | 2025 | Valtoco |
| Aimmune Therapeutics, INC. | $33.46 | 2024 | |
| Portola Pharmaceuticals, LLC | $33.31 | 2019 | |
| Ionis Pharmaceuticals, INC. | $32.70 | 2025 | Tryngolza |
| Abbott Laboratories | $32.31 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Proclaim |
| E.R. Squibb & Sons, L.L.C. | $30.05 | 2020-2021 | |
| Gilead Sciences, INC. | $29.40 | 2022-2024 | |
| Vifor Pharma, INC. | $24.08 | 2019 | |
| Ucb, INC. | $23.92 | 2019 | |
| Lundbeck LLC | $23.60 | 2025 | Rexulti |
| Astellas Pharma US INC | $23.45 | 2023 | Cresemba |
| Alexion Pharmaceuticals, INC. | $23.22 | 2023 | Ultomiris |
| Exact Sciences Corporation | $23.14 | 2024 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $22.29 | 2025 | Gvoke Hypopen |
| Melinta Therapeutics, LLC | $21.53 | 2023 | Kimyrsa, Vabomere |
| Ultragenyx Pharmaceutical INC. | $21.32 | 2023 | |
| Electromed, INC. | $19.81 | 2024 | Smartvest |
| Boston Scientific Corporation | $17.88 | 2023 | Watchman Access System |
| Edwards Lifesciences Corporation | $17.65 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Tetraphase Pharmaceuticals, INC. | $15.21 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $15.01 | 2024 | Sancuso |
| Amgen INC. | $14.47 | 2024 | Tezspire |
| Bayer Healthcare Pharmaceuticals INC. | $14.02 | 2024 | |
| Mylan Specialty L.P. | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.